We operate worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic. The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuroscience, pain, metabolic diseases as well as oncology and inflammation. Evotec has long-term discovery alliances with partners including Bayer, Boehringer Ingelheim, CHDI, Genentech, Janssen Pharmaceuticals, MedImmune/AstraZeneca and Ono Pharmaceutical.

Hamburg, DE
Size (employees)
1,316 (est)+7%
Evotec was founded in 1993 and is headquartered in Hamburg, DE
Report incorrect company information

Key People/Management at Evotec

Werner Lanthaler

Werner Lanthaler

Mario Polywka

Mario Polywka

Cord Dohrmann

Cord Dohrmann


Evotec Office Locations

Evotec has an office in South San Francisco, Hamburg, Branford, Princeton and in 8 other locations
Hamburg, DE (HQ)
7 Essener Bogen
Princeton, US (HQ)
303 College Rd E
Göttingen, DE
Planegg, DE
19A Am Klopferspitz
Toulouse, FR
195 Route d'Espagne
Verona, IT
4 Via Alessandro Fleming
Show all (13)
Report incorrect company information

Evotec Financials and Metrics

Evotec Financials

Market capitalization (3-Mar-2017)

1.1 b

Closing share price (3-Mar-2017)

Evotec's current market capitalization is €1.1 b.
Show all financial metrics

Evotec Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Aptuit July 30, 2017$300 m
Report incorrect company information

Evotec News and Updates

Myocarditis - Pipeline Review, H1 2018 with analysis by stage of development, drug target & molecule type

HTF Market Report released a new research document of 34 pages on industry titled as 'Myocarditis - Pipeline Review, H1 2018’ with detailed analysis, Competitive landscape, forecast and strategies. Posted via Industry Today. Follow us on Twitter @IndustryToday

Global Drug Discovery Outsourcing Market 2018 Industry Key Players: Evotec, Charles River Laboratories (CRL), Pharmaceutical Product Development (PPD), WuxiApptec, ChemPartner, Syngene,.

WiseGuyReports.com adds “Drug Discovery Outsourcing Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022”reports to its database. Posted via Industry Today. Follow us on Twitter @IndustryToday

WCAS sells Aptuit to Evotec for about $300 mln

Welsh, Carson, Anderson & Stowe has sold drug developer Aptuit to Evotec AG for about $300 million. Cravath, PWC, Cain Brothers and William Blair advised Aptuit on the deal while Evotec's advisers included Freshfields Bruckhaus Deringer, KPMG, Mercer and Rothschild.
Report incorrect company information